The guideline covers recommendations for primary care and other clinicians managing pain in outpatient settings and after patients are discharged from hospitals, EDs, or other facilities.
8 Nov 2022
There's no easy way to cure low back pain, but recommending a mix of therapies along with a dose of reassurance can often provide patients a measure of relief.
1 Nov 2022
For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
25 Oct 2022
A guideline from the Women's Preventive Services Initiative recommends physicians counsel women ages 40 to 60 years about healthy eating and physical activity to maintain weight or prevent weight gain.
2 Aug 2022
Prescriptions of antibiotics to U.S. adults with viral respiratory infections were associated with diarrhea, vulvovaginal candidiasis/vaginitis, and allergies, while use of an inappropriate antibiotic for bacterial infections was associated with nausea, vomiting, and abdominal pain.
15 Nov 2022
A recent simulation study estimated that a primary care clinician would require 26.7 h/d to provide preventive, chronic, and acute care, plus documentation/inbox management, to an average panel of 2,500 patients. This time decreased to 9.3 h/d with team-based care.
12 Jul 2022
The updated guideline recommends sodium-glucose cotransporter-2 inhibitors for many heart failure patients, regardless of their diabetes status, among other changes.
5 Apr 2022
An industry-funded cluster-randomized trial found that clinician alerts were associated with an over 40% increase in prescription of four recommended drug classes in patients with heart failure with reduced ejection fraction.
12 Apr 2022
The guideline from the American College of Cardiology/American Heart Association recommends that physicians talk to patients about risk-enhancing factors that can help provide a more personalized risk assessment, in addition to such traditional risk factors as smoking and high blood pressure.
20 Nov 2018
The American Thoracic Society strongly recommended LABA/LAMA combination therapy over monotherapy with either agent in patients with chronic obstructive pulmonary disease (COPD) and dyspnea or exercise intolerance, among other guidance.
21 Apr 2020